Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors

Benzer Materyaller

• Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR
  Yazar:: Della Corte, Carminia Maria, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Expression of Concern: Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
  Baskı/Yayın Bilgisi: (2019)
• Critical appraisal of the use of regorafenib in the management of colorectal cancer
  Yazar:: Festino, Lucia, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Antitumor efficacy of triple monoclonal antibody inhibition of epidermal growth factor receptor (EGFR) with MM151 in EGFR-dependent and in cetuximab-resistant human colorectal cancer cells
  Yazar:: Napolitano, Stefania, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidence
  Yazar:: Troiani, Teresa, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)